MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in CENPE define a novel kinetochore-centromeric mechanism for microcephalic primordial dwarfism.
|
24748105 |
2014 |
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Seckel syndrome
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CENPE define a novel kinetochore-centromeric mechanism for microcephalic primordial dwarfism.
|
24748105 |
2014 |
Seckel syndrome
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in CENPE define a novel kinetochore-centromeric mechanism for microcephalic primordial dwarfism.
|
24748105 |
2014 |
Seckel syndrome
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Liver carcinoma
|
0.320 |
Biomarker
|
disease |
BEFREE |
The clinical trials emerged centromere protein E inhibitor GSK923295 as a promising anticancer drug, but its function in hepatocellular carcinoma (HCC) remain needs to be fully elucidated, especially as chemotherapy after hepatectomy for liver tumors.
|
30681497 |
2019 |
Liver carcinoma
|
0.320 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
Liver carcinoma
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Together with other results, these results reveal that CENP-E expression was reduced in human HCC tissue, and low CENP-E expression result in aneuploidy in LO2 cells.
|
20021663 |
2009 |
Chronic myeloproliferative disorder
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Here, we described novel compound heterozygous variants in CENPE in two siblings who exhibit a profound MPD associated with developmental delay, simplified gyri and other isolated abnormalities.
|
24748105 |
2014 |
Chronic myeloproliferative disorder
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Intellectual Disability
|
0.110 |
GeneticVariation
|
group |
BEFREE |
The MCPH exhibits genetic heterogeneity with thirteen loci (MCPH1-MCPH13) identified, and associated with variable degree of intellectual disability.
|
28756000 |
2018 |
Intellectual Disability
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function.
|
29844566 |
2018 |
Testicular Germ Cell Tumor
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor.
|
28604732 |
2017 |
Testicular Germ Cell Tumor
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.
|
28604728 |
2017 |
Testicular Germ Cell Tumor
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.
|
25877299 |
2015 |
Testicular Neoplasms
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
|
23666240 |
2013 |
Testicular Germ Cell Tumor
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
|
23666240 |
2013 |
Cachexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Craniosynostosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|